Ondansetron and Penlac drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ondansetron (ondansetron) and Penlac (ciclopirox). Common drug interactions include drug ineffective among females and cataract among males.

The phase IV clinical study analyzes what interactions people have when they take Ondansetron and Penlac. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Ondansetron?

Ondansetron has active ingredients of ondansetron. It is often used in nausea. eHealthMe is studying from 122,738 Ondansetron users. Check the latest studies of Ondansetron.

What is Penlac?

Penlac has active ingredients of ciclopirox. eHealthMe is studying from 492 Penlac users. Check the latest studies of Penlac.

On Jul, 08, 2026

19 people who take Ondansetron and Penlac together, and have interactions are studied.

Ondansetron and Penlac drug interactions.

What are the common drug interactions of Ondansetron and Penlac, by gender? *:

female:

Drug ineffective
Erythema (redness of the skin)
Eye irritation
Pain
Chronic kidney disease
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Autoimmune disorder (a condition in which the immune system attacks the body's normal substances and tissue)
Constipation
Drug hypersensitivity
Muscular weakness (muscle weakness)

male:

Cataract (clouding of the lens inside the eye)
Prostatic disorder
Bone density decreased
Dehydration (dryness resulting from the removal of water)
Fall
Fatigue (feeling of tiredness)
Joint swelling
Scratch
Skin cancer
Staphylococcal bacteraemia (a bacterial infection of blood)

What are the common drug interactions of Ondansetron and Penlac, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Chronic kidney disease
Constipation
Muscular weakness (muscle weakness)
Peripheral sensory neuropathy (damage to one or more of your peripheral nerves)
Renal injury (kidney injury)
Stomatitis (inflammation of mucous membrane of mouth)
Surgery
Vision blurred
Hospitalisation

60+:

Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Bone density decreased
Chronic kidney disease
Dehydration (dryness resulting from the removal of water)
Fall
Fatigue (feeling of tiredness)
Joint swelling
Renal failure (kidney dysfunction)
Scratch

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 8 people, 42.11%
Pain: 4 people, 21.05%
Drowsiness: 2 people, 10.53%
Sleep Disorder: 2 people, 10.53%
Peripheral Sensory Neuropathy (damage to one or more of your peripheral nerves): 2 people, 10.53%
Palmar-Plantar Erythrodysaesthesia Syndrome (hand-foot syndrome): 2 people, 10.53%
Pain In Extremity: 2 people, 10.53%
Breast Cancer Metastatic: 2 people, 10.53%
Nail Disorder (disease of nail): 2 people, 10.53%
Stomatitis (inflammation of mucous membrane of mouth): 2 people, 10.53%

* Approximation only. Some reports may have incomplete information.

Do you take Ondansetron and Penlac?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously